CF
GILD icon

Cantor Fitzgerald’s Gilead Sciences GILD Stock Holding History

Cantor Fitzgerald’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$11.2M – 484
2025
Q1 		$11.2M Buy
+100,000
New +$10.3M 0.23% 30

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cantor Fitzgerald's GILD Position: Q2 2024 in Review

Cantor Fitzgerald sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 13,755 shares — an estimated $1.01M sold.

Cantor Fitzgerald first reported a position in GILD in Q1 2024 and held it in 1 quarter. The position peaked at $1.01M in Q1 2024. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Cantor Fitzgerald reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Cantor Fitzgerald sold 13,755 Gilead Sciences shares in Q2 2024, an estimated $1.01M.
  • Cantor Fitzgerald first reported a position in Gilead Sciences in Q1 2024 and held it in 1 quarter.
  • Cantor Fitzgerald's Gilead Sciences position peaked at $1.01M in Q1 2024.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.